Skip to main content
Premium Trial:

Request an Annual Quote

Sysmex, bioMérieux Form IVD Joint Venture in Japan

NEW YORK (GenomeWeb News) – Japanese diagnostic firm Sysmex will buy a 34 percent equity stake in bioMérieux’s Japanese subsidiary as part of an agreement to form a joint venture that will market bioMérieux’s in vitro diagnostics products in Japan.
 
The joint venture, which will hold the name Sysmex bioMérieux, will market bioMérieux’s entire product line in Japan beginning April 1. Prior to the agreement, bioMérieux’s Japanese operations were managed by its wholly owned subsidiary bioMérieux Japan.
 
The JV will manage regulatory filing and marketing activities for bioMérieux’s products while Sysmex has been contracted to handle sales and customer service activities.
 
Stéphane Bancel, CEO of bioMérieux, said that bioMérieux Japan had been “lacking scale in several critical functions like commercial operations and customer service.”
 
Bancel noted that Sysmex is currently the leading diagnostics company in the Japanese market, while bioMérieux Japan is “number 19 in the Japanese IVD market.”
 
As a result, he said, the agreement is expected to “bring bioMérieux’s innovative products to a broader Japanese customer base.”
 
BioMérieux said the Japanese microbiology testing market is around $30 billion yen ($274 million).
 
The agreement builds on a global partnership the companies began in July 2007, when bioMérieux agreed to distribute Sysmex’s automated UF-1000i urine sediment analyzer to its customer base.
 
BioMérieux said it expects to pay a non-recurring restructuring charge of around €2.5 million ($3.7 million) this year as a result of the joint venture.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.